We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CDRH Explains Itself as Ethicon Prepares to Defend Its Sedasys
CDRH Explains Itself as Ethicon Prepares to Defend Its Sedasys
December 10, 2010
As Johnson & Johnson (J&J) subsidiary Ethicon Endo-Surgery prepares to defend its computer-assisted personalized sedation system before an independent advisory panel convened by FDA Commissioner Margaret Hamburg, CDRH is finally explaining why it rejected the Sedasys device in the first place.